| Mary Kathleen Brown, NP | |
|
2223 Mission Way, Billings, MT 59102-0160 | |
| (406) 237-8282 | |
| Not Available |
| Full Name | Mary Kathleen Brown |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 2223 Mission Way, Billings, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477089332 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 125585 (Montana) | Primary |
| Entity Name | Cogent Healthcare Of Montana P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053569525 PECOS PAC ID: 4486712833 Enrollment ID: O20081029000254 |
News Archive
Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, as a potential target to weed out the progression of cancer. Although studies in the past have revealed that this enzyme plays a critical role in regulating the budding of tumours, scientists have for the first time unearthed a mechanism for its mode of action.
"The Obama administration took San Francisco's side Friday in a legal dispute over the city's groundbreaking health coverage law, urging the Supreme Court to reject an appeal by restaurant owners who objected to paying part of the cost. In a long-awaited filing, government lawyers said passage of national health insurance legislation 'has dramatically changed the landscape' and reduced the likelihood that cities and states would adopt laws like San Francisco's. The case presents no pressing issues that require the court's review, the lawyers said."
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
› Verified 6 days ago
| Entity Name | Hospitalist Medicine Physicians Of Nebraska-tcg, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487133963 PECOS PAC ID: 7911333810 Enrollment ID: O20200213001396 |
News Archive
Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, as a potential target to weed out the progression of cancer. Although studies in the past have revealed that this enzyme plays a critical role in regulating the budding of tumours, scientists have for the first time unearthed a mechanism for its mode of action.
"The Obama administration took San Francisco's side Friday in a legal dispute over the city's groundbreaking health coverage law, urging the Supreme Court to reject an appeal by restaurant owners who objected to paying part of the cost. In a long-awaited filing, government lawyers said passage of national health insurance legislation 'has dramatically changed the landscape' and reduced the likelihood that cities and states would adopt laws like San Francisco's. The case presents no pressing issues that require the court's review, the lawyers said."
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Kathleen Brown, NP 2223 Mission Way, Billings, MT 59102-0160 Ph: (406) 237-8282 | Mary Kathleen Brown, NP 2223 Mission Way, Billings, MT 59102-0160 Ph: (406) 237-8282 |
News Archive
Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, as a potential target to weed out the progression of cancer. Although studies in the past have revealed that this enzyme plays a critical role in regulating the budding of tumours, scientists have for the first time unearthed a mechanism for its mode of action.
"The Obama administration took San Francisco's side Friday in a legal dispute over the city's groundbreaking health coverage law, urging the Supreme Court to reject an appeal by restaurant owners who objected to paying part of the cost. In a long-awaited filing, government lawyers said passage of national health insurance legislation 'has dramatically changed the landscape' and reduced the likelihood that cities and states would adopt laws like San Francisco's. The case presents no pressing issues that require the court's review, the lawyers said."
Today's headlines include reports that the Obama administration plans to tweak the tax-penalty deadline for signing up for health insurance as well as previews of what might happen when the contractors who built the health law's online insurance marketplace testify today on Capitol Hill.
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
› Verified 6 days ago
Anna Victoria Nesovic, DNP, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-672-0927 | |
Rebekah Lee Brady, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1233 N 30th St, Billings, MT 59101 Phone: 435-851-9636 | |
Jeanne Randale Conner, MN, APRN, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3318 3rd Ave N, Billings, MT 59101 Phone: 406-248-3149 Fax: 406-245-6636 | |
Theresa Marie Shelton, NNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7417 Monad Rd, Billings, MT 59106 Phone: 406-861-0783 | |
Tish Ann Marie Parker, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 602 Henry Chapple St, Billings, MT 59106 Phone: 406-901-2300 | |
Melinda M Truesdell, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Anne Evelyn Mcrae, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1020 N 27th St, 410, Billings, MT 59102 Phone: 406-255-8550 |